Dr. Charles Fisher resigns from Aethlon board Nov 27; $460k severance, 50% option acceleration

AETHLON MEDICAL INC

Dr. Charles J. Fisher, Jr. resigns as director effective Nov 27, 2023; previously stepped down as CEO Nov 7.
Severance includes 12 months base salary ($460,000 total), paid over regular payroll schedule.
50% of outstanding unvested time-based stock options will accelerate and become fully vested.
COBRA healthcare premium reimbursement provided for up to 12 months post separation.
James B. Frakes, previously appointed Interim CEO, remains as interim CEO and CFO.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles J. Fisher, Jr.

Director

AEMD · AETHLON MEDICAL INC

Effective: 2023-11-27
Filed: November 27, 2023, 6:59 PM ET

Charles J. Fisher, Jr., M.D. has resigned from the board of directors of Aethlon Medical, Inc. (the “Company”), effective as of November 27, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles J. Fisher, Jr. resigned as Director at AETHLON MEDICAL INC.

Action: resigned
Role: Director

Exact text from the filing

Charles J. Fisher, Jr., M.D. has resigned from the board of directors of Aethlon Medical, Inc. (the “Company”), effective as of November 27, 2023

View on SEC.gov

AETHLON MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001683168-23-008454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.